Desco Infratech Regulatory Approval

Desco Infratech Other Announcement

Desco Infratech Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Listing Regulations.

Desco Infratech Annual General Meeting

Desco Infratech Limited announced voting results for its adjourned 15th AGM held on October 7, 2026. Shareholders approved all twelve resolutions including financial statements and director re-appointments.

Desco Infratech Management Change

Desco Infratech's shareholders approved the regularization of Mr. Shailesh Kalidas Naik as an Independent Director for a five-year term at the adjourned Annual General Meeting.

Desco Infratech Annual General Meeting

Desco Infratech adjourned its 15th Annual General Meeting due to lack of quorum. The meeting will reconvene on 7th October 2026.

Desco Infratech Bags ₹2.34 Cr Order from Adani Total Gas Limited

Desco Infratech received a Rs. 2.34 Crore order from Adani Total Gas for MDPE pipeline laying at Navsari. The award strengthens its gas pipeline order book.

Value

₹2.34 Cr

From

Adani Total Gas Limited (ATGL)

Desco Infratech Business Update

Desco Infratech was empaneled by NREDCAP for solar rooftop PV projects up to 500 KWp in Andhra Pradesh. No specific work order has been awarded.

RNFI Services Regulatory Approval

RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr